Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Plandai Biotechnology, Inc. (PLPL) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Plandai Biotechnology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1317880.
Total stock buying since 2013: $0.
Total stock sales since 2013: $122,500.
Total stock option exercises since 2013: $0.
▪ Recent SEC 13D filings for PLPL
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
A schedule 13D must be filed with the SEC when a person or group of people acquire beneficial ownership of more than 5% of Plandai Biotechnology, Inc. (PLPL). A schedule 13D/A is an amendment that is filed when there are any material changes in beneficial ownership.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 0 | $0 | 4,900,000 | $122,500 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-02 | 0 | $0 | 4,900,000 | $122,500 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-02-07 | Matula Timothy | Sale | 4,900,000 | .03 | 122,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of PLPL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Plandai Biotechnology, Inc. (symbol PLPL, CIK number 1317880) see the Securities and Exchange Commission (SEC) website.